Quarterly report pursuant to Section 13 or 15(d)

Our Portfolio - Schedule of Analysis of Portfolio Performance Ratings (Details)

v3.23.1
Our Portfolio - Schedule of Analysis of Portfolio Performance Ratings (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
Dec. 31, 2021
Financing Receivable, Nonaccrual [Line Items]        
2023 $ 31,000      
2022 683,000      
2021 285,000      
2020 164,000      
2019 463,000      
2018 270,000      
Prior to 2018 208,000      
Total receivables 2,104,000 $ 2,031,000    
Less: Allowance for loss on receivables (43,000) (41,000)    
Net receivables 2,061,000      
Receivables held-for-sale 16,603 85,254    
Investments 10,000      
Real estate 352,000      
Equity method investments 2,249,684 1,869,712    
Total $ 4,690,000      
Percent of Portfolio | Credit concentration risk        
Financing Receivable, Nonaccrual [Line Items]        
Percent of Portfolio 100.00%      
Government receivables        
Financing Receivable, Nonaccrual [Line Items]        
Total receivables $ 98,000 103,000    
Less: Allowance for loss on receivables 0 0 $ 0 $ 0
Net receivables 97,968 102,511    
Government receivables | 1        
Financing Receivable, Nonaccrual [Line Items]        
2023 0      
2022 0      
2021 0      
2020 0      
2019 0      
2018 0      
Prior to 2018 98,000      
Total receivables 98,000      
Less: Allowance for loss on receivables 0      
Net receivables 98,000      
Receivables held-for-sale 0      
Investments 2,000      
Real estate 0      
Equity method investments 0      
Total $ 100,000      
Government receivables | 1 | Percent of Portfolio | Credit concentration risk        
Financing Receivable, Nonaccrual [Line Items]        
Percent of Portfolio 2.00%      
Commercial receivables        
Financing Receivable, Nonaccrual [Line Items]        
Total receivables $ 2,006,000 1,928,000    
Less: Allowance for loss on receivables (43,000) (41,000) $ (37,000) $ (36,000)
Net receivables 1,962,793 $ 1,887,483    
Commercial receivables | 1        
Financing Receivable, Nonaccrual [Line Items]        
2023 31,000      
2022 683,000      
2021 285,000      
2020 164,000      
2019 461,000      
2018 270,000      
Prior to 2018 101,000      
Total receivables 1,995,000      
Less: Allowance for loss on receivables (38,000)      
Net receivables 1,957,000      
Receivables held-for-sale 17,000      
Investments 8,000      
Real estate 352,000      
Equity method investments 2,227,000      
Total $ 4,561,000      
Commercial receivables | 1 | Percent of Portfolio | Credit concentration risk        
Financing Receivable, Nonaccrual [Line Items]        
Percent of Portfolio 97.00%      
Commercial receivables | 2        
Financing Receivable, Nonaccrual [Line Items]        
2023 $ 0      
2022 0      
2021 0      
2020 0      
2019 0      
2018 0      
Prior to 2018 0      
Total receivables 0      
Less: Allowance for loss on receivables 0      
Net receivables 0      
Receivables held-for-sale 0      
Investments 0      
Real estate 0      
Equity method investments 23,000      
Total $ 23,000      
Commercial receivables | 2 | Percent of Portfolio | Credit concentration risk        
Financing Receivable, Nonaccrual [Line Items]        
Percent of Portfolio 1.00%      
Commercial receivables | 3        
Financing Receivable, Nonaccrual [Line Items]        
2023 $ 0      
2022 0      
2021 0      
2020 0      
2019 2,000      
2018 0      
Prior to 2018 9,000      
Total receivables 11,000      
Less: Allowance for loss on receivables (5,000)      
Net receivables 6,000      
Receivables held-for-sale 0      
Investments 0      
Real estate 0      
Equity method investments 0      
Total $ 6,000      
Commercial receivables | 3 | Percent of Portfolio | Credit concentration risk        
Financing Receivable, Nonaccrual [Line Items]        
Percent of Portfolio 0.00%